DEEPMIND'S HASSABIS SEES AI-DESIGNED DRUG TRIALS THIS YEAR

Summary from the TLDR newsletter

Isomorphic Labs' Nobel Prize-winning chief executive officer says that the company will hopefully have some AI-designed drugs in clinical trials by the end of the year. It is working on shortening the drug discovery process from a decade or more to just weeks or months. The company, created in 2021 to commercialize Google DeepMind's AlphaFold AI for drug discovery, announced strategic research collaboration agreements with Eli Lilly & Co. and Novartis AG last year. AlphaFold can model a range of molecular structures and predict how they interact with each other.